ELI LILLY & Co is 1247.6x more valuable than Olema Pharmaceuticals, Inc. by market capitalization ($1.070 T vs $857.75 M). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | OLMA | LLY |
|---|---|---|
| Market cap | $857.75 M | $1.070 T |
| US-listed rank | #2657 | #10 |
| Revenue (latest FY) | - | $65.18B |
| Net income (latest FY) | -$162.45M | $20.64B |
| Net margin | - | 31.7% |
| P/E (trailing FY) | - | 51.8 |
| SEC filings | 538 | 989 |
ELI LILLY & Co is 1247.6x more valuable than Olema Pharmaceuticals, Inc. by market capitalization ($1.070 T vs $857.75 M).
Full pages: Olema Pharmaceuticals, Inc. and ELI LILLY & Co, or browse the full rankings.